Unknown OBSERVATIONAL NCT04065945

Epigenetic Safety of Assisted Reproductive Technology

Epigenetic Safety of Various Protocols in Assisted Reproductive Technology

Sponsor: Changhai Hospital

Interventions Completion questionnaires/providing biological samples

Updated 7 times since 2019 Last updated: Aug 21, 2019 Started: Sep 15, 2019 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Infertility and is currently ongoing. Changhai Hospital leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Feb 2025 — Present [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Dec 2021 — Jul 2024 [monthly]

Not Yet Recruiting
Jan 2021 — Dec 2021 [monthly]

Not Yet Recruiting

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting
Sep 2019 — Nov 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhai Hospital
International Peace Maternity and Child Health Hospital
Women's Hospital School Of Medicine Zhejiang University

Data source: Women's Hospital School Of Medicine Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China